Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Pejman, Molaei"'
Publikováno v:
پژوهان, Vol 20, Iss 3, Pp 188-193 (2022)
Background and Objectives: Acute lymphocytic leukemia (ALL) is a type of cancer that affects white blood cells. The disease progresses rapidly mandating immediate treatment. ALL is the most common type of leukemia affecting children. An increase in t
Externí odkaz:
https://doaj.org/article/5d54d9c887aa4423805cf5a3ab5c70c4
Publikováno v:
Protein & Peptide Letters. 29:651-675
Background: To recognize the action of pharmacologically approved anticancer drugs in biological systems, information regarding its pharmacokinetics, such as its transport within the plasma and delivery to its target site, is essential. In this study
Autor:
Pejman Molaei, Rahele Amir Daddost, Hanie Mahaki, Elham Lotfiane, Yaghoub Ahmadyousefi, Masoomeh Vahidzadeh, Zeynab Nasr Isfahani, Hamid Tanzadehpanah, Mohammad-Hadi Saeed Modaghegh
Publikováno v:
International Journal of Peptide Research and Therapeutics. 27:2527-2542
Recently, peptide-based materials have been applied to solving many therapeutic problems and have shown particular efficacy as cancer immunotherapies, including early diagnosis, prognostic predictors, and the treatment of cancer patients by interacti
Publikováno v:
Neurochemical Research.
Cholestasis is a bile flow reduction that is induced following Bile Duct Ligation (BDL). Cholestasis impairs memory and induces apoptosis. Apoptosis consists of two pathways: intrinsic and extrinsic. The intrinsic pathway is modulated by BCL-2 (B cel
Autor:
Mojdeh Amini Faskhoudi, Pejman Molaei, Mehrdokht Sadrkhanloo, Sima Orouei, Mehrdad Hashemi, Saied Bokaie, Mohsen Rashidi, Maliheh Entezari, Ali Zarrabi, Kiavash Hushmandi, Sepideh Mirzaei, Mohammad Hossein Gholami
Publikováno v:
Pathology - Research and Practice. 233:153851
The c-Myc signaling is a new emerging target in cancer therapy. Activation of c-Myc signaling leads to cancer growth and invasion in vitro and in vivo. The stability of c-Myc can also mediate drug resistance and radioresistance in cancers. The apopto